$NGM NGM BIOPHARMACEUTICALS INC Insider Trading Week 14/2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NGM BIOPHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NGM BIOPHARMACEUTICALS INC in week 14/2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | LESCHLY MARK | Director | Option Exercise | C | 0.00 | 166,667 | 0 | 0 | |
| Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | LESCHLY MARK | Director | Option Exercise | C | 0.00 | 600,000 | 0 | 0 | |
| Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | LESCHLY MARK | Director | Option Exercise | C | 0.00 | 3,000,000 | 0 | 0 | |
| Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | LESCHLY MARK | Director | Buy | C | 0.00 | 3,766,667 | 0 | 3,766,667 | 0 to 3.8 M |
| Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Option Exercise | C | 0.00 | 3,400,000 | 0 | 0 | |
| Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Option Exercise | C | 0.00 | 2,377,334 | 0 | 0 | |
| Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Option Exercise | C | 0.00 | 8,408,933 | 0 | 0 | |
| Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Option Exercise | C | 0.00 | 12,000,000 | 0 | 0 | |
| Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | C | 0.00 | 13,093,134 | 0 | 15,444,091 | 2.4 M to 15.4 M (+556.93 %) |
| Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 16.00 | 1,875,000 | 30,000,000 | 2,350,957 | 476 K to 2.4 M (+393.94 %) |
| Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 16.00 | 20,000 | 320,000 | 20,000 | 0 to 20 K |
| Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Option Exercise | C | 0.00 | 3,400,000 | 0 | 0 | |
| Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Option Exercise | C | 0.00 | 2,377,334 | 0 | 0 | |
| Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Option Exercise | C | 0.00 | 8,488,933 | 0 | 0 | |
| Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Option Exercise | C | 0.00 | 12,300,000 | 0 | 0 | |
| Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 16.00 | 1,875,000 | 30,000,000 | 15,634,091 | 13.8 M to 15.6 M (+13.63 %) |
| Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | C | 0.00 | 13,283,134 | 0 | 13,759,091 | 476 K to 13.8 M (+2,790.83 %) |
| Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Option Exercise | C | 0.00 | 3,400,000 | 0 | 0 | |
| Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Option Exercise | C | 0.00 | 2,377,334 | 0 | 0 | |
| Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Option Exercise | C | 0.00 | 8,408,933 | 0 | 0 | |
| Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Option Exercise | C | 0.00 | 12,000,000 | 0 | 0 | |
| Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 16.00 | 15,000 | 240,000 | 15,000 | 0 to 15 K |
| Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 16.00 | 1,875,000 | 30,000,000 | 1,875,000 | 0 to 1.9 M |
| Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | C | 0.00 | 13,093,134 | 0 | 13,569,091 | 476 K to 13.6 M (+2,750.91 %) |
| Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | SCHNELL DAVID | Director | Option Exercise | C | 0.00 | 100,000 | 0 | 0 | |
| Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | SCHNELL DAVID | Director | Option Exercise | C | 0.00 | 525,000 | 0 | 0 | |
| Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | SCHNELL DAVID | Director | Option Exercise | C | 0.00 | 1,300,000 | 0 | 0 | |
| Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | SCHNELL DAVID | Director | Option Exercise | C | 0.00 | 3,000,000 | 0 | 0 | |
| Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | SCHNELL DAVID | Director | Buy | C | 0.00 | 4,925,000 | 0 | 4,925,000 | 0 to 4.9 M |
| Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | TICHENOR MCHENRY T | Director | Option Exercise | C | 0.00 | 50,000 | 0 | 0 | |
| Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | TICHENOR MCHENRY T | Director | Option Exercise | C | 0.00 | 166,666 | 0 | 0 | |
| Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | TICHENOR MCHENRY T | Director | Option Exercise | C | 0.00 | 1,616,666 | 0 | 0 | |
| Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | TICHENOR MCHENRY T | Director | Buy | C | 0.00 | 1,833,332 | 0 | 1,872,314 | 39 K to 1.9 M (+4,703.02 %) |
| Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | Hooper Suzanne Sawochka | Director | Buy | P | 16.00 | 7,000 | 112,000 | 7,000 | 0 to 7 K |
| Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | RIEFLIN WILLIAM JL | Executive Chairman | Option Exercise | C | 0.00 | 6,668 | 0 | 0 | |
| Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | RIEFLIN WILLIAM JL | Executive Chairman | Option Exercise | C | 0.00 | 50,000 | 0 | 0 | |
| Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | RIEFLIN WILLIAM JL | Executive Chairman | Buy | C | 0.00 | 56,668 | 0 | 2,769,168 | 2.7 M to 2.8 M (+2.09 %) |
| Apr 09 2019 | NGM | NGM BIOPHARMACEUTI ... | Merck & Co., Inc. | 10% Owner | Option Exercise | C | 0.00 | 17,666,666 | 0 | 0 | |
| Apr 09 2019 | NGM | NGM BIOPHARMACEUTI ... | Merck & Co., Inc. | 10% Owner | Buy | P | 16.00 | 4,121,683 | 65,946,928 | 12,955,016 | 8.8 M to 13 M (+46.66 %) |
| Apr 09 2019 | NGM | NGM BIOPHARMACEUTI ... | Merck & Co., Inc. | 10% Owner | Buy | C | 0.00 | 8,833,333 | 0 | 8,833,333 | 0 to 8.8 M |